查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722879

2025 年至 2033 年抗蛇毒市场规模、份额、趋势及预测（按物种、抗蛇毒类型、作用方式、最终用户和地区划分）

Anti-venom Market Size, Share, Trends and Forecast by Species, Anti-Venom Type, Mode of Action, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球抗蛇毒市场规模价值 12.401 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 20.597 亿美元，2025-2033 年期间的复合年增长率为 5.8%。北美目前占据市场主导地位，到 2024 年将占据超过 37.8% 的显着市场。蛇咬和蝎子螫伤发生率的上升、政府有利倡议的实施以及行业的持续创新是推动市场成长的一些关键因素。

抗蛇毒血清，也称为毒液抗血清，是指用于治疗蛇、蜘蛛、蝎子和某些海洋生物（如水母或芋螺）的毒咬或蜇伤的一种药物。它是透过从犯罪动物中提取毒液，然后将少量毒液注射到马、羊或山羊等动物体内而获得的，这些动物的免疫系统会产生抗体，这些抗体被收集和纯化以产生抗毒液。抗蛇毒血清可以中和毒素并抵消蛇毒的作用，防止其引起呼吸衰竭或器官损伤等危及生命的併发症。此方法在世界各地被广泛用于治疗毒咬和蜇伤，具体方法取决于病史、检查以及地理、临床和病理因素。

抗毒液市场趋势：

世界各地毒咬和蜇伤案件的增加，特别是在农村和热带地区以及农业工人和猎人中，是推动市场成长的主要因素之一。除此之外，消费者对预防蛇咬伤重要性的认识不断提高，而且产品价格实惠，易于获得，为市场前景创造了良好的前景。此外，政府为应对蛇咬伤而实施的多项倡议，如教育和培训计划，以及对新型抗蛇毒产品研发活动的大量投资，都促进了市场的成长。此外，随着对动物性蛋白质的需求不断增加，面临蛇咬伤风险的牲畜和其他动物的数量也在增加，这反过来又为市场带来了有利可图的成长机会。同时，旅行和探索岛屿、沙漠、丛林和狩猎等异国目的地的日益流行，使游客面临被蛇咬伤和遭遇其他有毒动物的风险，这是另一个重要的成长诱因。此外，生物技术和医疗保健行业的许多技术进步以及製造技术的持续创新改进，使得生产更有效、更有效率的抗蛇毒产品成为可能，这对市场成长产生了积极影响。除此之外，各种快速蛇毒检测试剂盒的推出正在推动市场向前发展，这些试剂盒利用快速酶联免疫吸附试验，透过从咬伤部位、尿液、血浆、血液或其他组织和体液中采集的样本来检测和识别蛇毒。

本报告回答的关键问题

  • 什么是抗蛇毒血清？抗蛇毒市场有多大？
  • 2025 年至 2033 年期间全球抗蛇毒市场预期成长率为何？
  • 推动全球抗蛇毒市场发展的关键因素有哪些？
  • 根据物种划分，全球抗蛇毒市场的主要细分市场是什么？
  • 根据抗蛇毒类型，全球抗蛇毒市场的主要细分市场是什么？
  • 根据作用方式，全球抗蛇毒市场的主要部分是什么？
  • 根据最终用户来看，全球抗蛇毒市场的主要细分市场是什么？
  • 全球抗蛇毒市场的主要区域有哪些？
  • 全球抗蛇毒市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球抗蛇毒市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依物种

  • 蛇
  • 蝎
  • 蜘蛛
  • 其他的

第七章：市场区隔：依抗毒类型

  • 多价抗蛇毒血清
  • 单价抗蛇毒血清

第八章：市场区隔：依行动模式

  • 细胞毒性
  • 神经毒性
  • 血液毒性
  • 心臟毒性
  • 肌肉毒性
  • 其他的

第九章：市场区隔：依最终用户

  • 医院
  • 诊所
  • 门诊手术中心

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Bharat Serums and Vaccines Limited (BSV)
    • Boehringer Ingelheim International GmbH
    • Boston Scientific Corporation
    • CSL Limited
    • Haffkine Bio-Pharmaceutical Corporation Limited
    • Incepta Pharmaceuticals Limited
    • Merck & Co. Inc.
    • Merck KGaA
    • MicroPharm Limited
    • Pfizer Inc.
    • Rare Disease Therapeutics Inc.
Product Code: SR112025A5147

The global anti-venom market size was valued at USD 1,240.1 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,059.7 Million by 2033, exhibiting a CAGR of 5.8% during 2025-2033. North America currently dominates the market, holding a significant market share of over 37.8% in 2024. The rising incidences of snake bites and scorpion stings, the implementation of favorable government initiatives, and ongoing innovations in the industry represent some of the key factors driving the market toward growth.

Anti-venom, also known as venom antiserum, refers to a type of medication used to treat the effects of venomous bites or stings from animals, including snakes, spiders, scorpions, and certain marine creatures such as jellyfish or cone snails. It is obtained by extracting venom from the offending animal and then injecting small amounts of the venom into animals, such as horses, sheep, or goats, whose immune systems produce antibodies that are harvested and purified to create anti-venom. Anti-venom neutralizes the toxins and counteracts the effects of the venom, preventing them from causing life-threatening complications such as respiratory failure or organ damage. It is extensively adopted across the globe in treating venomous bites and stings, depending on their history, examination, and geographic, clinical, and pathologic factors.

Anti-Venom Market Trends:

The rise in cases of venomous bites and stings across the world, particularly in rural and tropical regions and among agricultural workers and hunters, represents one of the prime factors driving the market growth. Besides this, the escalating consumer awareness of the importance of snake bite prevention and easy product availability at an affordable price is creating a favorable outlook for the market. Moreover, the implementation of numerous government initiatives to combat snake bites, such as education and training programs, and intensive investments in research and development (R&D) activities of new anti-venom products are contributing to the market growth. In addition to this, with the rising demand for animal-based protein, there is an increase in the number of livestock and other animals at risk of snake bites, which, in turn, is presenting remunerative growth opportunities for the market. Concurrent with this, the rising popularity of traveling and exploring exotic destinations, such as islands, deserts, jungles, and safaris, that puts tourists at risk of snake bites and other venomous animal encounters is acting as another significant growth-inducing factor. Furthermore, numerous technological advancements in the biotechnology and healthcare industries and ongoing innovative improvements in manufacturing technology, allowing for the production of more effective and efficient anti-venom products, are positively impacting the market growth. Apart from this, the launch of various rapid snake venom detection kits, which utilize a rapid enzyme immunoassay to detect and identify snake venom through samples taken from bite sites, urine, plasma, blood, or other tissues and body fluids, is propelling the market forward.

Key Market Segmentation:

Species Insights:

  • Snake
  • Scorpion
  • Spider
  • Others

Anti-venom Type Insights:

  • Polyvalent Anti-venom
  • Monovalent Anti-venom

Mode of Action Insights:

  • Cytotoxic
  • Neurotoxic
  • Haemotoxic
  • Cardiotoxic
  • Myotoxic
  • Others

End User Insights:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for anti-venom. Some of the factors driving the North America anti-venom market included the increasing incidence of snake bites, the introduction of numerous favorable government initiatives, and the thriving travel and tourism sector.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global anti-venom market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH, Boston Scientific Corporation, CSL Limited, Haffkine Bio-Pharmaceutical Corporation Limited, Incepta Pharmaceuticals Limited, Merck & Co. Inc., Merck KGaA, MicroPharm Limited, Pfizer Inc., and Rare Disease Therapeutics Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.What is anti-venom?
  • 2.How big is the anti-venom market?
  • 3.What is the expected growth rate of the global anti-venom market during 2025-2033?
  • 4.What are the key factors driving the global anti-venom market?
  • 5.What is the leading segment of the global anti-venom market based on the species?
  • 6.What is the leading segment of the global anti-venom market based on anti-venom type?
  • 7.What is the leading segment of the global anti-venom market based on the mode of action?
  • 8.What is the leading segment of the global anti-venom market based on the end user?
  • 9.What are the key regions in the global anti-venom market?
  • 10.Who are the key players/companies in the global anti-venom market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anti-venom Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Species

  • 6.1 Snake
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Scorpion
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Spider
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Anti-venom Type

  • 7.1 Polyvalent Anti-venom
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Monovalent Anti-venom
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Mode of Action

  • 8.1 Cytotoxic
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Neurotoxic
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Haemotoxic
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cardiotoxic
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Myotoxic
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Ambulatory Surgical Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bharat Serums and Vaccines Limited (BSV)
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Boehringer Ingelheim International GmbH
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Boston Scientific Corporation
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CSL Limited
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Haffkine Bio-Pharmaceutical Corporation Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Incepta Pharmaceuticals Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck & Co. Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Merck KGaA
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 MicroPharm Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Rare Disease Therapeutics Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Anti-venom Market: Major Drivers and Challenges
  • Figure 2: Global: Anti-venom Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Anti-venom Market: Breakup by Species (in %), 2024
  • Figure 5: Global: Anti-venom Market: Breakup by Anti-venom Type (in %), 2024
  • Figure 6: Global: Anti-venom Market: Breakup by Mode of Action (in %), 2024
  • Figure 7: Global: Anti-venom Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Anti-venom Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Anti-venom (Snake) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Anti-venom (Snake) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Anti-venom (Scorpion) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Anti-venom (Scorpion) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Anti-venom (Spider) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Anti-venom (Spider) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Anti-venom (Other Species) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Anti-venom (Other Species) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Anti-venom (Polyvalent Anti-venom) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Anti-venom (Polyvalent Anti-venom) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Anti-venom (Monovalent Anti-venom) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Anti-venom (Monovalent Anti-venom) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Anti-venom (Cytotoxic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Anti-venom (Cytotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Anti-venom (Neurotoxic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Anti-venom (Neurotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Anti-venom (Haemotoxic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Anti-venom (Haemotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Anti-venom (Cardiotoxic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Anti-venom (Cardiotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Anti-venom (Myotoxic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Anti-venom (Myotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Anti-venom (Other Mode of Actions) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Anti-venom (Other Mode of Actions) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Anti-venom (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Anti-venom (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Anti-venom (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Anti-venom (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Anti-venom (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Anti-venom (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: North America: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: North America: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: United States: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: United States: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Canada: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Canada: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Asia-Pacific: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Asia-Pacific: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: China: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: China: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Japan: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Japan: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: India: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: India: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: South Korea: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: South Korea: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Australia: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Australia: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Indonesia: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Indonesia: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Europe: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Europe: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Germany: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Germany: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: France: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: France: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: United Kingdom: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: United Kingdom: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Italy: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Italy: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Spain: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Spain: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Russia: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Russia: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Latin America: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Latin America: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Brazil: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Brazil: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Mexico: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Mexico: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Others: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Others: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Middle East and Africa: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Middle East and Africa: Anti-venom Market: Breakup by Country (in %), 2024
  • Figure 87: Middle East and Africa: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Global: Anti-venom Industry: SWOT Analysis
  • Figure 89: Global: Anti-venom Industry: Value Chain Analysis
  • Figure 90: Global: Anti-venom Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anti-venom Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Anti-venom Market Forecast: Breakup by Species (in Million USD), 2025-2033
  • Table 3: Global: Anti-venom Market Forecast: Breakup by Anti-venom Type (in Million USD), 2025-2033
  • Table 4: Global: Anti-venom Market Forecast: Breakup by Mode of Action (in Million USD), 2025-2033
  • Table 5: Global: Anti-venom Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Anti-venom Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Anti-venom Market: Competitive Structure
  • Table 8: Global: Anti-venom Market: Key Players